Inventor
KANIA ROBERT STEVEN
US32 patents
⚠️ This page may combine multiple inventors who share the name “KANIA ROBERT STEVEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PFIZER
18 patentsUS8680111B2Mar 25, 2014
Macrocyclic derivatives for the treatment of diseases
PFIZER54 citations96
US10766884B2Sep 8, 2020
Cyclin dependent kinase inhibitors
PFIZER19 citations92
US7696213B2Apr 13, 2010
4-methylpyridopyrimidinone compounds
PFIZER21 citations91
US11220494B2Jan 11, 2022
Cyclin dependent kinase inhibitors
PFIZER13 citations84
US9481666B2Nov 1, 2016
Substituted dihydroisoquinolinone compounds
PFIZER12 citations83
US7732604B2Jun 8, 2010
Triazolopyrazine derivatives
PFIZER11 citations83
US9133215B2Sep 15, 2015
Macrocyclic derivatives for the treatment of diseases
PFIZER16 citations82
US10570121B2Feb 25, 2020
Substituted dihydroisoquinolinone compounds
PFIZER2 citations72
US10125130B2Nov 13, 2018
Cycloalkyl-linked diheterocycle derivatives
PFIZER2 citations71
US12378232B2Aug 5, 2025
Cyclin dependent kinase inhibitors
PFIZER0 citations61
US11684616B2Jun 27, 2023
Azalactam compounds as HPK1 inhibitors
PFIZER1 citations56
US12485157B2Dec 2, 2025
Method of treating COVID-19
PFIZER0 citations50
US12358897B2Jul 15, 2025
Compounds and method of treating COVID-19
PFIZER0 citations50
US11203594B2Dec 21, 2021
Anti-proliferative agents for treating PAH
PFIZER0 citations50
US10676471B2Jun 9, 2020
Cycloalkyl-linked diheterocycle derivatives
PFIZER0 citations50
US7772246B2Aug 10, 2010
Pyrazole compounds as RAF inhibitors
PFIZER0 citations50
US11142525B2Oct 12, 2021
Azalactam compounds as HPK1 inhibitors
PFIZER0 citations47
US11926642B2Mar 12, 2024
Compounds and methods for the treatment of COVID-19
PFIZER0 citations42
AGOURON PHARMA
11 patentsUS6884890B2Apr 26, 2005
Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
AGOURON PHARMA178 citations98
US6534524B1Mar 18, 2003
Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
AGOURON PHARMA277 citations98
US7141587B2Nov 28, 2006
Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
AGOURON PHARMA17 citations92
US6891044B2May 10, 2005
Indazole compounds and pharmaceutical compositions for Inhibiting protein kinases, and methods for their use
AGOURON PHARMA20 citations92
US7053107B2May 30, 2006
Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
AGOURON PHARMA12 citations83
US7208500B2Apr 24, 2007
Thienopyridine-phenylacetamides and their derivatives useful as new anti-angiogenic agents
AGOURON PHARMA10 citations82
US6833456B2Dec 21, 2004
Indolyl-urea derivatives of thienopyridines useful as antiangiogenic agents, and methods for their use
AGOURON PHARMA20 citations81
US7381824B2Jun 3, 2008
Quinoline derivatives
AGOURON PHARMA7 citations73
US6869962B2Mar 22, 2005
Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
AGOURON PHARMA6 citations71
US7923457B2Apr 12, 2011
Quinoline derivatives
AGOURON PHARMA0 citations52
US7045528B2May 16, 2006
Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
AGOURON PHARMA1 citations49